OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study
Anna Feeney, Rebecca S. Hock, Marlene P. Freeman, et al.
European Neuropsychopharmacology (2021) Vol. 49, pp. 122-132
Open Access | Times Cited: 24
Anna Feeney, Rebecca S. Hock, Marlene P. Freeman, et al.
European Neuropsychopharmacology (2021) Vol. 49, pp. 122-132
Open Access | Times Cited: 24
Showing 24 citing articles:
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
Fabrice Jollant, Romain Colle, Thi Mai Loan Nguyen, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 33
Fabrice Jollant, Romain Colle, Thi Mai Loan Nguyen, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 33
A Randomized Double-Blind Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation
Tung‐Ping Su, Cheng‐Ta Li, Wei‐Chen Lin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 331-339
Open Access | Times Cited: 24
Tung‐Ping Su, Cheng‐Ta Li, Wei‐Chen Lin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 331-339
Open Access | Times Cited: 24
Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
Alice Caldiroli, Enrico Capuzzi, Ilaria Tagliabue, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13070-13070
Open Access | Times Cited: 41
Alice Caldiroli, Enrico Capuzzi, Ilaria Tagliabue, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13070-13070
Open Access | Times Cited: 41
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs
Marco Solmi, Chaomei Chen, Charles Daure, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 44-60
Open Access | Times Cited: 31
Marco Solmi, Chaomei Chen, Charles Daure, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 44-60
Open Access | Times Cited: 31
Pharmacotherapy
Anna Feeney, George I. Papakostas
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 277-290
Closed Access | Times Cited: 17
Anna Feeney, George I. Papakostas
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 277-290
Closed Access | Times Cited: 17
A meta-analysis of the effects of ketamine on suicidal ideation in depression patients
Z. Shen, Daiquan Gao, Xue Lv, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Z. Shen, Daiquan Gao, Xue Lv, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Suicide and Inflammation
Jennifer J. Donegan, Charles B. Nemeroff
Advances in experimental medicine and biology (2023), pp. 379-404
Closed Access | Times Cited: 13
Jennifer J. Donegan, Charles B. Nemeroff
Advances in experimental medicine and biology (2023), pp. 379-404
Closed Access | Times Cited: 13
Clinical trials since 2020 of rapid anti-suicidal ideation effects of ketamine and its enantiomers: a systematic review
Sumra Sajid, J. John Mann, Michael F. Grunebaum
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Sumra Sajid, J. John Mann, Michael F. Grunebaum
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Measuring suicidal behavior in the era of rapid-acting antidepressants: a systematic review of ketamine studies
Flávia Vieira, Ana Teresa Caliman‐Fontes, Breno Souza‐Marques, et al.
Psychiatry Research (2025), pp. 116443-116443
Closed Access
Flávia Vieira, Ana Teresa Caliman‐Fontes, Breno Souza‐Marques, et al.
Psychiatry Research (2025), pp. 116443-116443
Closed Access
HIV-related stigma, depression and suicidal ideation among HIV-positive MSM in China: a moderated mediation model
Jiaqi Fu, Xu Chen, Zhenwei Dai, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Jiaqi Fu, Xu Chen, Zhenwei Dai, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?
Aistė Lengvenytė, Robertas Strumila, Émilie Olié, et al.
European Neuropsychopharmacology (2022) Vol. 57, pp. 88-104
Open Access | Times Cited: 15
Aistė Lengvenytė, Robertas Strumila, Émilie Olié, et al.
European Neuropsychopharmacology (2022) Vol. 57, pp. 88-104
Open Access | Times Cited: 15
A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression
Yating Wang, Xiaole Wang, Lei Lan, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 2, pp. 287-296
Closed Access | Times Cited: 8
Yating Wang, Xiaole Wang, Lei Lan, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 2, pp. 287-296
Closed Access | Times Cited: 8
New investigational agents for the treatment of major depressive disorder
Bartłomiej Pochwat, Anna Julia Krupa, Marcin Siwek, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 1053-1066
Closed Access | Times Cited: 13
Bartłomiej Pochwat, Anna Julia Krupa, Marcin Siwek, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 1053-1066
Closed Access | Times Cited: 13
Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
Yanling Zhou, Chengyu Wang, Xiaofeng Lan, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 11
Yanling Zhou, Chengyu Wang, Xiaofeng Lan, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 11
Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates
Francesco Bartoli, Bianca Bachi, Tommaso Callovini, et al.
CNS Spectrums (2023) Vol. 29, Iss. 1, pp. 49-53
Open Access | Times Cited: 6
Francesco Bartoli, Bianca Bachi, Tommaso Callovini, et al.
CNS Spectrums (2023) Vol. 29, Iss. 1, pp. 49-53
Open Access | Times Cited: 6
Stress, mental disorder and ketamine as a novel, rapid acting treatment
Megan Dutton, Adem Can, Jim Lagopoulos, et al.
European Neuropsychopharmacology (2022) Vol. 65, pp. 15-29
Closed Access | Times Cited: 8
Megan Dutton, Adem Can, Jim Lagopoulos, et al.
European Neuropsychopharmacology (2022) Vol. 65, pp. 15-29
Closed Access | Times Cited: 8
(Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy
Alexandra Alario, Mark J. Niciu
Chronic Stress (2022) Vol. 6
Open Access | Times Cited: 8
Alexandra Alario, Mark J. Niciu
Chronic Stress (2022) Vol. 6
Open Access | Times Cited: 8
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review
Julia M. K. Freind, Fernando R. Beserra, Bruno S. Menezes, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 496-512
Closed Access | Times Cited: 4
Julia M. K. Freind, Fernando R. Beserra, Bruno S. Menezes, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 496-512
Closed Access | Times Cited: 4
Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder
Ruyun Liu, Ning Liu, Lin Ma, et al.
CNS Drugs (2024) Vol. 38, Iss. 12, pp. 985-1002
Closed Access | Times Cited: 1
Ruyun Liu, Ning Liu, Lin Ma, et al.
CNS Drugs (2024) Vol. 38, Iss. 12, pp. 985-1002
Closed Access | Times Cited: 1
Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis
Jiafeng Li, Ma Ling, Huan Sun, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 1
Jiafeng Li, Ma Ling, Huan Sun, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 1
The Role of Rapid-Acting Antidepressants in Suicidal Crisis Management
Aistė Lengvenytė, Marco Sarchiapone, Miriam Iosue, et al.
Cambridge University Press eBooks (2024), pp. 259-276
Closed Access
Aistė Lengvenytė, Marco Sarchiapone, Miriam Iosue, et al.
Cambridge University Press eBooks (2024), pp. 259-276
Closed Access
Efficacy of single and repeated ketamine administration for suicidal ideation in adults with psychiatric disorders: A meta-analysis
Wanting Feng, Chengfeng Chen, Yexian Zeng, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111152-111152
Closed Access
Wanting Feng, Chengfeng Chen, Yexian Zeng, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111152-111152
Closed Access
Ketamine’s efficacy in alleviating acute suicidal thoughts: a comprehensive systematic review and meta-analysis
Seyedeh Asrin Seyedoshohadaei, Ramyar Rahimi Darehbagh, Farshid Gholami, et al.
Middle East Current Psychiatry (2024) Vol. 31, Iss. 1
Open Access
Seyedeh Asrin Seyedoshohadaei, Ramyar Rahimi Darehbagh, Farshid Gholami, et al.
Middle East Current Psychiatry (2024) Vol. 31, Iss. 1
Open Access
A synopsis of multitarget therapeutic effects of anesthetics on depression
Guowei Wu, Hongwei Xu
European Journal of Pharmacology (2023) Vol. 957, pp. 176032-176032
Closed Access
Guowei Wu, Hongwei Xu
European Journal of Pharmacology (2023) Vol. 957, pp. 176032-176032
Closed Access
